Advisor Group Holdings, Inc. Astrazeneca PLC Transaction History
Advisor Group Holdings, Inc.
- $44.4 Billion
- Q2 2025
A detailed history of Advisor Group Holdings, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 132,725 shares of AZN stock, worth $10 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
132,725
Previous 169,900
21.88%
Holding current value
$10 Million
Previous $12.5 Million
25.73%
% of portfolio
0.02%
Previous 0.03%
Shares
23 transactions
Others Institutions Holding AZN
# of Institutions
1,414Shares Held
499MCall Options Held
7.24MPut Options Held
2.65M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$3.91 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.1 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.59 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.37 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.35 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $233B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...